A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma
NCT05712083 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2023-02-21
Summary
Clinical Trial for the Safety and Efficacy of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma
Conditions
- Multiple Myeloma
- New Diagnosis Tumor
Interventions
- DRUG
-
BCMA CAR-T cells
Each subject receive BCMA CAR T-cells by intravenous infusion
Sponsors & Collaborators
-
Yake Biotechnology Ltd.
collaborator INDUSTRY -
Zhejiang University
lead OTHER
Principal Investigators
-
He Huang, MD · First Affiliated Hospital of Zhejiang University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-30
- Primary Completion
- 2024-04-01
- Completion
- 2024-04-01
Countries
- China
Study Locations
More Related Trials
-
BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma
NCT03093168 ·Status: UNKNOWN ·Phase: PHASE1
-
BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
NCT04271644 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia
NCT06762132 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
NCT04272151 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
NCT04776330 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
NCT03751293 ·Status: UNKNOWN ·Phase: PHASE1
-
Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
NCT04706936 ·Status: UNKNOWN ·Phase: PHASE1
-
NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
NCT04658004 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma
NCT03716856 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible
NCT07070960 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
NCT04295018 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma
NCT03758417 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies
NCT02954445 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor
NCT04650724 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma
NCT07196124 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
NCT04662294 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
BCMA CAR-T Cell Therapy in High-risk NDMM Patients With Positive MRD After First-line ASCT
NCT05846737 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
NCT03815383 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of BCMA CAR-T in Multiple Myeloma
NCT03322735 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
NCT06581640 ·Status: RECRUITING ·Phase: PHASE2
-
Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
NCT07144020 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
BCMA CAR-T for Dynamic High-risk Multiple Myeloma
NCT06880393 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple Myeloma
NCT04186052 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Study of the Safety and Efficacy of BCMA CAR-NK
NCT05652530 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients
NCT07169500 ·Status: RECRUITING ·Phase: PHASE1/PHASE2